• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经局部应用干扰素 α2b 治疗后的眼表面炎症行羊膜移植。

Amniotic Membrane Grafting for Ocular Surface Inflammation Following Topical Interferon Alpha 2b Therapy.

机构信息

Department of Cornea and Anterior Segment, Eye Life, Mumbai, Maharashtra, India.

Ophthalmic Pathology Laboratory, LV Prasad Eye Institute, Hyderabad, Telangana, India.

出版信息

J Interferon Cytokine Res. 2022 Mar;42(3):137-139. doi: 10.1089/jir.2021.0191.

DOI:10.1089/jir.2021.0191
PMID:35298286
Abstract

We describe a rare case of a 58-year-old female with ocular surface squamous neoplasia (OSSN) in her left eye. She was treated for 12 months with topical interferon alpha-2b (IFNα-2b) eye drops and OSSN resolved completely. She presented with a whitish elevated lesion involving the cornea, limbus, and conjunctival surface after discontinuation of topical IFNα-2b. Excision biopsy along with amniotic membrane grafting was done to stabilize the ocular surface. Histopathological evaluation of the excised tissue revealed ocular surface inflammation with no evidence of malignancy.

摘要

我们描述了一例左眼眼表面鳞状上皮瘤(OSSN)的 58 岁女性罕见病例。她接受了 12 个月的局部干扰素 alpha-2b(IFNα-2b)滴眼治疗,OSSN 完全消退。停用局部 IFNα-2b 后,她出现了累及角膜、角膜缘和结膜表面的白色隆起性病变。为稳定眼表面,进行了切除活检和羊膜移植。切除组织的组织病理学评估显示眼表面炎症,无恶性证据。

相似文献

1
Amniotic Membrane Grafting for Ocular Surface Inflammation Following Topical Interferon Alpha 2b Therapy.经局部应用干扰素 α2b 治疗后的眼表面炎症行羊膜移植。
J Interferon Cytokine Res. 2022 Mar;42(3):137-139. doi: 10.1089/jir.2021.0191.
2
Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.局部应用干扰素α-2b在“丝裂霉素C耐药”的眼表鳞状上皮肿瘤中的作用:我们的初步研究结果。
Int Ophthalmol. 2019 Feb;39(2):295-301. doi: 10.1007/s10792-017-0811-0. Epub 2018 Jan 23.
3
Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia.眼局部用干扰素α-2b 滴眼剂作为眼表面鳞状上皮肿瘤的主要治疗方法的长期研究。
Ocul Surf. 2023 Apr;28:108-114. doi: 10.1016/j.jtos.2022.12.009. Epub 2022 Dec 30.
4
Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.局部应用干扰素α-2b治疗23例眼表鳞状上皮肿瘤:基于美国癌症联合委员会分类的结果
Arch Ophthalmol. 2012 Feb;130(2):159-64. doi: 10.1001/archophthalmol.2011.385.
5
Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.局部应用干扰素α-2b单一疗法治疗原发性眼表鳞状上皮肿瘤
Asia Pac J Ophthalmol (Phila). 2015 Sep-Oct;4(5):279-82. doi: 10.1097/APO.0000000000000104.
6
Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.丝裂霉素C或干扰素作为眼表鳞状上皮肿瘤手术辅助治疗的比较研究。
Eur J Ophthalmol. 2018 Mar;28(2):204-209. doi: 10.5301/ejo.5001035. Epub 2017 Nov 9.
7
Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia.眼局部应用干扰素α-2b 在眼表面鳞状上皮肿瘤切除术后辅助治疗中的作用。
In Vivo. 2019 Nov-Dec;33(6):2211-2215. doi: 10.21873/invivo.11724.
8
Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.眼表面鳞状上皮肿瘤的局部 5-氟尿嘧啶和干扰素 Alfa-2b 作为主要治疗方式的比较。
Am J Ophthalmol. 2019 Mar;199:216-222. doi: 10.1016/j.ajo.2018.11.007. Epub 2018 Nov 22.
9
Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.局部应用干扰素或手术切除治疗原发性眼表鳞状上皮肿瘤
Ophthalmology. 2008 Aug;115(8):1297-302, 1302.e1. doi: 10.1016/j.ophtha.2008.01.006. Epub 2008 Feb 21.
10
Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b.局部应用 5-氟尿嘧啶治疗对干扰素 α-2b 治疗抵抗的结膜上皮内瘤变的疗效和安全性。
J Oncol Pharm Pract. 2023 Jun;29(4):975-979. doi: 10.1177/10781552221125763. Epub 2022 Sep 21.